Assessing pain after cancer treatment

Nina Lykkegaard Gehr; Kristine Bennedsgaard; Lise Ventzel; Nanna Brix Finnerup

doi:10.1515/sjpain-2022-0093

Assessing pain after cancer treatment

Scand J Pain. 2022 Aug 8;22(4):676-678. doi: 10.1515/sjpain-2022-0093. Print 2022 Oct 26.

Authors

Nina Lykkegaard Gehr¹, Kristine Bennedsgaard², Lise Ventzel³, Nanna Brix Finnerup^{1

4}

Affiliations

¹ Department of Clinical Medicine, Danish Pain Research Center, Aarhus University, Aarhus, Denmark.
² Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
³ Department of Oncology, University Hospital of Southern Denmark, Vejle, Denmark.
⁴ Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.

PMID: 35934881
DOI: 10.1515/sjpain-2022-0093

Abstract

Objectives: Chronic pain is common following cancer treatment. This is a brief discussion of pain assessment after cancer treatment.

Methods: Summary of a lecure for the SASP (Scandinavian Journal of Pain) annual meeting 2022.

Results: Assessment of pain involves identifying the presence of pain, its underlying cause, its impact as well as underlying mechanisms.

Conclusions: Detailed pain assessment is important for the clinic and for epidemiological and mechanistic studies as well as pain treatment studies.

Keywords: cancer; chemotherapy; chronic pain; neuropathy; pain; surgery.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Chronic Pain* / therapy
Humans
Neoplasms* / complications
Neoplasms* / therapy
Pain Management
Pain Measurement